1) NT-probrain natriuretic peptide
氨基酸末端脑钠肽前体
2) N-terminal pro-brain natriuretic peptide
氨基末端脑钠肽前体
1.
Objective:To explore the plasma N-terminal pro-brain natriuretic peptide(NT-proBNP) level of neonates with neonatal asphyxia and its clinical significance.
目的:探讨窒息新生儿血浆氨基末端脑钠肽前体(NT-proBNP)水平及临床意义。
2.
Serum N-terminal pro-brain natriuretic peptide levels on the prognosis of multiple organ dysfunction syndrome in the elderly;
目的探讨老年多器官功能不全综合征(MODSE)患者血清氨基末端脑钠肽前体(NT-proBNP)水平变化及其临床意义。
3) NT-proBNP
氨基末端-脑钠肽前体
1.
Diagnostic value of NT-proBNP in the differentiation of acute dyspnea;
急诊呼吸困难患者氨基末端-脑钠肽前体的鉴别诊断价值
4) NT-proBNP
氨基末端脑钠肽前体
1.
To study the relationship between N-temrina probarin natriuretic peptide(NT-proBNP) level and cardiac functions in patients with congestive heart failure(CHF),the plasma level of NT-proBNP in 108 patients with CHF and 30 healthy controls were measured by electrochemiluminescence immunoassay(ECLIA) and left ventricular ejection fraction(LVEF) was measured by echocardiography.
探讨充血性心力衰竭(CHF)患者血浆氨基末端脑钠肽前体(NT-proBNP)水平与心功能的关系。
2.
Diastolic dysfunction is one of the important triggers for the release of brain natriuretic petide(BNP) and N-terminal pro-natriuretic petide(NT-proBNP) from the ventricular myocardium.
舒张功能不全是触发心肌细胞释放脑钠肽(BNP)和氨基末端脑钠肽前体(NT-proBNP)的重要因素。
3.
Methods HFEI in 116 patients with CHF(CHF group) and 24 normal controls(control group) were evaluated and compared with the levels of contemporaneous NT-ProBNP and the NYHA class, and the sensitivity and specificity of HFEI for CHF diagnosis were appraised.
方法:前瞻性研究慢性心力衰竭患者116例(心衰组),正常者24例(对照组),所有入选者进行心衰超声指数的评分,并将该评分与同期血浆氨基末端脑钠肽前体(NT-ProBNP)水平及纽约心功能分级(NYHA)进行比较,同时评价其诊断慢性心力衰竭的敏感性与特异性。
5) N-terminal fragment pro-brain natriuretic peptide
氨基酸末端脑钠素前体
1.
Objective To investigate the relationship between serum N-terminal fragment pro-brain natriuretic peptide( NT-proBNP) levels and atrial fibrillation (AF).
目的探讨血清中氨基酸末端脑钠素前体(NT-proBNP)水平与心房颤动(房颤)之间的关系。
6) NT-BNP
氨基末端脑钠肽
1.
Objective: To compare the effects of insulin plus rosiglitazone with insulin plus metformin on serum N-terminal pro-brain natriuretic peptide(NT-BNP), adiponectin, leptin and C reaction protein(CRP) in type 2 diabetes mellitus.
目的：比较胰岛素和罗格列酮联合治疗与胰岛素和二甲双胍联合治疗两种方案对2型糖尿病患者血清氨基末端脑钠肽(NT-BNP)、脂联素、瘦素及C反应蛋白(CRP)水平的影响。
补充资料：氨基
分子式：
CAS号：
性质：氨分子中去掉一个氢原子后，剩下的一价基团，结构式：—NH2。当它与烃基相连时，组成伯胺。与脂肪烃基相连为脂肪族伯胺（R—NH2）、与芳烃基相连为芳香族伯胺（Ar—NH2）。当氨基与苯环相连时，可使苯环致活，再进基主要进入其邻（o-）、对（p-）位。
CAS号：
性质：氨分子中去掉一个氢原子后，剩下的一价基团，结构式：—NH2。当它与烃基相连时，组成伯胺。与脂肪烃基相连为脂肪族伯胺（R—NH2）、与芳烃基相连为芳香族伯胺（Ar—NH2）。当氨基与苯环相连时，可使苯环致活，再进基主要进入其邻（o-）、对（p-）位。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条